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ABSTRACT
Peripheral nerves are highly regenerative, in contrast to the poor
regenerative capabilities of the central nervous system (CNS). Here,
we show that adult peripheral nerve is a more quiescent tissue than
the CNS, yet all cell types within a peripheral nerve proliferate
efficiently following injury. Moreover, whereas oligodendrocytes are
produced throughout life from a precursor pool, we find that the
corresponding cell of the peripheral nervous system, the myelinating
Schwann cell (mSC), does not turn over in the adult. However,
following injury, all mSCs can dedifferentiate to the proliferating
progenitor-like Schwann cells (SCs) that orchestrate the regenerative
response. Lineage analysis shows that these newly migratory,
progenitor-like cells redifferentiate to form new tissue at the injury
site and maintain their lineage, but can switch to become a non-
myelinating SC. In contrast, increased plasticity is observed during
tumourigenesis. These findings show that peripheral nerves have a
distinct mechanism for maintaining homeostasis and can regenerate
without the need for an additional stem cell population.
This article has an associated ‘The people behind the papers’
interview.
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INTRODUCTION
Once formed in the adult, peripheral nerves are relatively stable
structures, befitting their role in transmitting signals back and forth
between tissues and organs and the central nervous system (CNS).
However, in contrast to the CNS, peripheral nerves are able to
regenerate following an injury (Mahar and Cavalli, 2018). This
requires not only the regrowth of the neurons but the creation of new
tissue to repair the wound site, together with the remodelling of the
remaining nerve tissue to provide an environment conducive for
axonal regrowth (Cattin and Lloyd, 2016; Zochodne, 2012). Crucial
to this regenerative process is the main glial cell of the peripheral
nervous system (PNS), the Schwann cell (SC). In the adult, SCs exist
in one of two states: myelinating Schwann cells (mSCs), which
myelinate larger axons in a 1:1 ratio, and non-myelinating Schwann
cells (nmSCs), which bundle together groups of smaller axons in
structures known as Remak bundles (Harty and Monk, 2017; Monk
et al., 2015). Following injury, these highly specialised cells have the
capacity to dedifferentiate to a proliferating, progenitor-like SC, which
orchestrates the regenerative response (Jessen and Mirsky, 2016;
Napoli et al., 2012). The roles of SCs in this process include guiding
regrowing axons across the injury site (Cattin et al., 2015; Parrinello
et al., 2010), opening the blood-nerve barrier (BNB) and controlling
the inflammatory response (Napoli et al., 2012), remodelling the
nerve environment (Brosius Lutz et al., 2017) and promoting the
growth and survival of the regrowing axons (Arthur-Farraj et al.,
2012; Fontana et al., 2012). Once the axons have regrown, the
dedifferentiated SCs are thought to redifferentiate in response to
axonal signals, and the regenerative state resolves to return to the
homeostatic state (Cattin and Lloyd, 2016; Zochodne, 2008).
The behaviour of mSCs is in stark contrast to that of the
comparable cells of the CNS, the oligodendrocyte (OLs). Once an
OL has myelinated a neuron, it is postmitotic in that it cannot return
to a proliferative state. Moreover, new OLs are produced throughout
life, either to replace OLs or to myelinate previously unmyelinated
axon segments (Birey et al., 2017; Young et al., 2013). This de novo
myelination in adulthood is thought to contribute to the plasticity of
the brain in processes such as learning and memory (Kaller et al.,
2017; McKenzie et al., 2014). New OLs are produced from a
continuously slowly proliferating pool of progenitor cells that exist
throughout the CNS, known as oligodendrocyte progenitor cells
(OPCs) (Dimou and Simons, 2017; Kang et al., 2010). These cells
continuously produce newOLs in the adult (Young et al., 2013) and
following demyelination events in pathologies such as multiple
sclerosis (Domingues et al., 2016).
It is not clear why the CNS and PNS have evolved distinct
mechanisms to produce new cells and have such different
regenerative capabilities. Moreover, the apparent lack of a stem
cell/progenitor population in the PNS to produce new cells, either
during homeostasis or following injury, is unusual for a mammalian
tissue. This has led to speculation that an additional stem cell
population contributes to the production of new SCs during the
regenerative process (Amoh et al., 2005; Chen et al., 2012;
McKenzie et al., 2006), and that SCs retain some of the
multipotency that SC precursors exhibit during development in
order to regenerate new nerve tissue (Petersen and Adameyko,Received 23 July 2018; Accepted 30 October 2018
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2017). In this study, we have characterised the behaviour of all cell
types within peripheral nerve during homeostasis and during the
regenerative process. Moreover, we have used lineage analysis to
track the behaviour and fate of mSCs. We find that peripheral nerve
is a highly quiescent tissue and that, in contrast to OLs, mSCs do not
turn over in adulthood. Following injury, however, all cell types
within the nerve proliferate, with close to 100% of mSCs entering
the cell cycle to become migratory, progenitor-like SCs, which
orchestrate the multicellular nerve regeneration process without the
requirement for a distinct SC stem cell population. Lineage analysis
shows that these ‘repair’ SCs retain the SC lineage, but can switch
from a mSC to a nmSC. In contrast, we find that this restriction
breaks down during SC tumourigenesis, when these cells show
increased plasticity. This work shows that peripheral nerve is a
tissue with a distinct mechanism for both maintaining homeostasis
and regenerating following injury – in that cells rarely turn over in
the homeostatic state, whereas all cells in the tissue proliferate and
contribute to the repair of the damaged nerve. This study also
demonstrates the remarkable stability of glia in the PNS, despite
retaining the ability to efficiently convert to a progenitor-like SC
following injury, providing a further illustration of the diversity of
stem/progenitor cell phenotypes that exist in mammalian tissues.
RESULTS
Identification of the cell composition of peripheral nerve
In order to determine the composition and turnover of cells found in
a peripheral nerve, we initially systematically determined the cell
composition within the endoneurium of mouse sciatic nerve. To do
this, we used a number of transgenic mice with lineage-specific
expression of fluorescent labels, along with immunostaining of
endogenous markers to quantify the prevalence of each cell type
using immunofluorescence (IF) and electron microscopy (EM)
analysis. Consistent with previous findings (Salonen et al., 1988),
we found that the vast majority of cells within the sciatic nerve are
SCs (∼70%), as determined by staining for the cytoplasmic SC
marker S100 (S100B) and by EM analysis (Fig. 1A,B). Moreover,
Fig. 1. Identification of the cell composition of
peripheral nerve. (A) Representative confocal IF
and EM images, showing the SC population in
transverse sections of mouse sciatic nerve. SCs
are labelled by staining with anti-S100 antibody
(red) or endogenously in PLP-eGFP mice
(green). In the EM image, a nmSC is coloured
purple while a typical mSC is coloured green.
(B) Quantification shows the proportions of SCs
in mouse sciatic nerve (n=4 mice, mean±s.e.m.).
(C) Pie chart showing the percentages of
individual cell types within sciatic nerve.
Cryosections of sciatic nerves were
immunolabelled with cell type-specific markers
as indicated (n=4). The NG2+/PDGFRβ+/p75+/
αSMA− population is classified as either
associated or non-associated with CD31+ blood
vessels (BV). Pericytes are defined as NG2+/
PDGFRβ+/αSMA+. (D) Representative images of
transverse mouse sciatic nerve sections labelled
as indicated. (i) Arrowhead indicates a p75+ cell
(red) that is not associated with axons [labelled
with antibody against neurofilament (NF), white].
(ii) Arrowhead indicates a p75+ cell (red) that is
not associated with axons (labelled for NF, white)
and does not express eGFP in nerves isolated
from PLP-eGFP mice. (iii) Arrowhead indicates a
PLP-eGFP−/p75+/NG2+ cell. (iv) Arrowhead
indicates a PLP-eGFP−/NG2+/PDGFRβ+ cell.
(v) Arrow indicates an αSMA+/p75− pericyte in
close contact with a CD31+ blood vessel (white).
(vi) Arrow indicates a p75+ cell that co-expresses
dsRed in nerves isolated from NG2-dsRed mice
and is loosely associated with a CD31+ blood
vessel. The asterisk indicates a p75+/dsRed+ cell
that is not associated with a blood vessel.
(v,vi) Dashed line boxes indicate the regions that
are shown at higher magnification in insets. See
also Fig. S1.
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these results were confirmed by imaging nerve sections from a
transgenic mouse in which all SCs express eGFP (PLP-eGFPmice)
(Fig. 1A) (Mallon et al., 2002), and by immunostaining for myelin
protein zero (P0; Mpz) (Fig. S1A) and p75 (Ngfr) (Fig. S1B). This
analysis also confirmed that the majority of cells were mSCs (51%),
with the ratio of mSCs to nmSCs (21%) roughly 2:1 (Fig. 1B,C,
Fig. S1C).
p75 has been used extensively as a marker to label both nmSCs
and the dedifferentiated SCs that form following an injury (Jessen
et al., 2015). However, we also found a significant proportion of
p75+ cells that did not appear to be associated with axons and had a
distinct elongated morphology (Fig. 1D). Moreover, these p75+
cells did not express eGFP in nerves isolated from PLP-eGFP mice
(Fig. 1D) or tdTomato in nerves from P0-Cre:tdTomato mice that
express tdTomato in all SCs (Fig. S1D). Instead, we found that these
cells (p75+/eGFP−) expressed the commonly used markers for
pericytes, NG2 (Cspg4) and PDGFRβ (Fig. 1D) (Armulik et al.,
2011). Moreover, we confirmed NG2 expression in these cells, by
analysing nerves from mice that express dsRed by virtue of an NG2-
driven expression construct (NG2-dsRed mice) (Zhu et al., 2008), and
found a complete overlap between NG2/PDGFRβ immunostaining
and dsRed expression (Fig. 1D, Fig. S1E).
We could distinguish three populations of NG2+/PDGFRβ+ cells
within the nerve endoneurium. The first population (1.5% of total
cells within the endoneurium) had all the characteristics of classical
pericytes. They co-expressed NG2 and PDGFRβ (data not shown),
were negative for p75 and expressed α-smooth muscle actin
(αSMA; Acta2) (Fig. 1D). Moreover, they were found tightly
associated around blood vessels [CD31+ (Pecam1+) cells] (Fig. 1D),
consistent with a pericyte population that could be observed within
the basal lamina around the blood vessels by EM (Fig. S1F). A
much larger population of NG2+/PDGFRβ+ cells (12.5%) was p75+
(Fig. 1C). They were also S100– (Fig. S1G) and were not labelled in
PLP-eGFP mice or in P0-Cre:tdTomato mice (Fig. 1D, Fig. S1D),
and so appeared not to be SCs or derived from SCs. We also noticed
that a proportion of these cells were found loosely associated with
blood vessels (4.5%) (Fig. 1D), whereas others appeared to be within
the endoneurium away from blood vessels (Fig. 1D, Fig. S1E); thus,
although we were unable to distinguish these two populations by
markers, we classified them as blood vessel associated (4.5%) or non-
associated (8%) (Fig. 1C, Fig. S1C). It is important to note that EM
analysis showed that, while some of these cells were associated with
blood vessels, they were not found within the basal lamina of the
vessels (Fig. S1H). EM analysis also showed high amounts of
endoplasmic reticulumwithin these cells, indicating that they are cells
that have provisionally been identified as neural crest-derived
fibroblasts by others (Joseph et al., 2004) (Fig. S1H).
The remaining cells of peripheral nerve were shown to be
endothelial cells (6%, CD31+) and macrophages [8%, F4/80+
(Adgre1+)/Iba1+] (Fig. 1C, Fig. S1C). We did not detect other
inflammatory cells, such as mast cells, neutrophils or dendritic cells,
within the uninjured nerves (data not shown). In conclusion, we
have been able to identify all cell types within the endoneurium of
the nerve and have characterised the tools to enable us to trace their
behaviour in normal nerve and following injury.
mSCs do not proliferate in the adult
The CNS is relatively quiescent compared with many tissues of the
body; however, cumulative long-term 5-ethynyl-2′-deoxyuridine
(EdU) labelling studies have shown that essentially all OPCs
proliferate, albeit slowly, with turnover times ranging from∼1 week
to >1 month in different regions of the brain, spinal cord and optic
nerve (Young et al., 2013). To determine the overall proliferation
rate of cells within the endoneurium of peripheral sciatic nerve, we
used the same protocol of cumulative EdU labelling to mark
proliferating cells in adult mice. For each time point (8, 30 and
70 days), we calculated the percentage of cells that had accumulated
EdU and this increased in a linear manner over time, showing that
the proliferation rate remained constant during early adulthood
(Fig. 2A). However, the overall proliferation rate was very low
(∼0.8% per week), with fewer than 10% of the cells labelled within
the 70-day time period. This implies that if all cells within the nerve
were proliferating at the same rate, the tissue turnover time would
be ∼2.4 years. These findings highlight the quiescent nature of
peripheral nerve.
To determine the identity of the proliferating cells within the
nerve, we used the cell type-specific markers defined above
(Fig. 2B, Fig. S2A). Analysis of the long-term labelling studies
showed that mSCs appeared to be completely quiescent, as we failed
to detect a single EdU+ mSC over the 70-day labelling period. This
implies that mSCs, once formed, do not turn over. In contrast, we
detected a very low level of EdU+ nmSCs in Remak bundles
(Fig. 2B). We confirmed the identity of these cells by the detection
of EdU+/eGFP+ cells in EdU-dosed PLP-eGFP mice (Fig. 2C,
Fig. S2B) and the association of EdU+ nuclei within eGFP+ Remak
structures in 3D reconstructions (Movie 1). However, we found that
the nmSC turnover ratewas extremely slow (∼72 months) (Fig. 2D).
Thus, the glial cells of the PNS show very different proliferative
dynamics to the corresponding cells of the CNS. No newmSCs, and
very few new nmSCs, are produced in the adult, whereas new OLs
are produced throughout life (Young et al., 2013).
The most highly proliferative cell type in peripheral nerve was the
resident macrophages, with a turnover time of ∼4 months (Fig. 2D,
Fig. S2A). This is somewhat similar to the turnover rate of the resident
macrophage population (microglia) in the brain (Askew et al., 2017;
Tay et al., 2017). All other cell types also showed low, but detectable,
levels of turnover, with endothelial cells, NG2+/PDGFRβ+/p75+/
αSMA− cells and pericytes showing approximate turnover rates of
15, 7.5 and 6 months, respectively (Fig. 2D, Fig. S2A).
All mSCs proliferate following injury
The analysis of homeostatic peripheral nerve demonstrated a mostly
quiescent tissue, consistent with its stable architecture. However,
peripheral nerves are highly regenerative, requiring that the tissue
retains plasticity. Following an injury, the distal stump of the nerve
undergoes extensive breakdown, followed by clearance of debris,
regrowth and remodelling to reform a functional nerve (Cattin and
Lloyd, 2016; Zochodne, 2008). SCs have a key role in orchestrating
the regenerative process, and have been reported to dedifferentiate
following injury to pursue this role (Cattin and Lloyd, 2016; Jessen
and Mirsky, 2016). However, it remains unclear whether all SCs
have this capacity, whether a smaller ‘stem-like’ compartment is
involved or whether new SCs derive from other stem cell
compartments to regenerate the nerve. To distinguish between
these possibilities, we performed lineage analysis using a transgenic
mouse, which allows Cre expression to be specifically induced in
mSCs in the adult (P0-CreERT2:YFP) following tamoxifen
administration (Leone et al., 2003; Ribeiro et al., 2013).
To analyse the initial stages of the regenerative process and to
investigate the proliferative potential of mSCs, we performed
cumulative EdU labelling following sciatic nerve transection in
P0-CreERT2:YFP adult mice, 14 days following tamoxifen
treatment (Fig. 3A). Analysis of the distal stump (downstream of
the cut and the newly formed bridge region) showed a dramatic
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switch in the proliferative status of the nerve, with >80% of cells
within the nerve accumulating EdU by Day 8 following injury
(Fig. 3A). Remarkably, despite being completely quiescent in the
adult nerve, >80% of the YFP+ (mSC-derived) cells in the nerve
proliferated within 6 days of the injury, with close to 100%
proliferating by Day 10. This result showed that, despite being
completely quiescent in the adult, all mSCs have the capacity to
proliferate following an injury (Fig. 3A, Fig. S3A).
In order to determine the kinetics of mSC proliferation following
an injury, we performed EdU pulse labelling after nerve transection
and found that the peak mSC proliferation was at Day 4 following
injury, with the rates returning to lower, but still detectable, levels
at Day 8-10 following injury (Fig. 3B, Fig. S3B). Total cell
proliferation followed a similar trend, demonstrating a robust
proliferative burst of all the identified cell types within the nerve, as
the myelin structures break down within the injured nerve (Fig. 3B,
Fig. S3C). Notably, the endothelial cells in the distal stump did not
enter the cell cycle until after Day 4, indicating that, at this time
point, new blood vessels have not formed within the distal stump.
This is in contrast to what was reported previously for the bridge
region of a transected nerve, where newly formed blood vessels
have an important role in the regenerative process (Cattin et al.,
2015). This analysis also showed there was an increase in the
proportion of two cell types within the nerve: macrophages that
increased from 8% to 22%, following the recruitment of monocytes
from the blood stream, and NG2+, PDGFRβ+ αSMA− cells that
increased from 12% to 22%, reflecting the higher proliferative rate
of this cell type (Fig. 3C, Fig. S3D). Furthermore, neutrophils and
other inflammatory cells are recruited into regenerating nerve, most
likely accounting for the minor unknown cell population at this time
point (Napoli et al., 2012).
A crucial aspect of SC behaviour during the regeneration of a
transected nerve is that they become migratory, forming cellular
cords that transport regrowing axons across the injury site
Fig. 2. Peripheral nerve is a highly quiescent
tissue. (A) EdU was administered continuously in
the drinking water of wild-type mice for 8, 30 and
70 days. Cryosections of sciatic nerve were
processed to detect EdU. Graph shows the mean
percentages (±s.e.m.) of EdU+ cells that
accumulate over time (n=3-4 mice). (B)
Cryosections of sciatic nerves were labelled with
cell-specific markers and processed to detect EdU+
cells (n=3-4 mice, ±s.e.m.). (C) 3D projection of a
confocal image of a 20 μm cryosection of sciatic
nerve isolated from aPLP-eGFPmouse treatedwith
EdU continuously for 30 days, showing an EdU+
(red) eGFP+ nmSC associated with small axons
[labelled with antibody against neurofilament (NF),
white]. (D) Pie chart showing the proportion of
proliferating cell types in adult sciatic nerve in mice
treated with EdU for 30 days (n=6 mice). The NG2+/
PDGFRβ+/p75+/αSMA− population is classified as
either associated or non-associated with CD31+
blood vessels (BV). Graph shows the calculated
turnover time for each cell population. See also Fig.
S2 and Movie 1.
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(Parrinello et al., 2010). However, it is not clear whether both
nmSCs and mSCs are able to undergo this marked change in
migratory behaviour. To track the migration of individual SCs, we
administered tamoxifen to P0-CreERT2:Confetti mice (Snippert
et al., 2010), so that individual mSCs stochastically expressed
a combination of four fluorophores (nuclear localised GFP,
membrane-targeted Cyan and cytoplasmic RFP or YFP),
generating ten possible distinct colour combinations (Fig. 4A).
Following injury, SCs of each colour could be observed migrating
into the bridge (Fig. 4B). Moreover, we found different coloured
cells migrating next to each other in the cellular cords (Fig. 4C), and
these mSC-derived cells were associated with axons in the injury
region (Fig. 4D, Fig. S4A). These results show that previously
quiescent mSCs can undergo extensive structural and functional
remodelling to become highly migratory cells within a few days of
an injury, and that they are a polyclonal population. We also
observed a significant number of p75+ cells in the migrating cellular
cords that were not labelled with a confetti-derived fluorophore
(Fig. 4B). This suggested that nmSC-derived cells also contributed
to the SC population migrating out of the nerve stumps into
the bridge.
To confirm that the non-labelled p75+ population was SCs and
not the NG2+/PDGFRβ+ population, we took a number of
approaches. Analysis of transverse sections of the bridge region
from PLP-eGFP:NG2-dsRed mice found that only 5.14±2.5%
(mean±s.e.m., n=4) of the cells in the bridge were NG2+/p75+/
eGFP−. Moreover, longitudinal sections of the bridge region
showed that these cells were not present within the migrating cell
cords (Fig. S4C). In addition, analysis of transverse sections of the
bridge region from P0-Cre:tdTomato mice (in which all SCs are
labelled with tdTomato) revealed that the vast majority of p75+
within the bridge are also tdTomato positive [95.2±2.1% (mean±
s.e.m., n=6)]. Together, these results demonstrate that the migratory
population is derived from a combination of nmSCs and mSCs. To
Fig. 3. All mSCs proliferate following injury.
(A) Schematic showing the protocol to assess
accumulated proliferation of mSCs following injury.
P0-CreERT2:YFP mice were treated with tamoxifen
(Tmx) for 5 days to specifically label mSCs with YFP.
Fourteen days later, the right sciatic nerve was
transected, and EdU was administered continuously
in the drinking water for 10 days. Mice were harvested
at the indicated time points and proliferating (EdU+)
cells were counted in cryosections of the distal stump
(downstream of the newly formed bridge region) of
sciatic nerve processed for IF staining. Graphs show
the percentage of proliferating cells (EdU+/Hoechst+)
or the percentage of proliferating mSCs (YFP+, EdU+/
YFP+) plotted against the time of EdU administration
(n=4mice, ±s.e.m.). Representative images show that
few mSCs have proliferated at Day 3 following injury.
In contrast, almost all mSCs have proliferated by Day
10 postinjury. Arrowheads indicate proliferating
mSCs. (B) Schematic showing the protocol used to
perform a temporal analysis of the proliferation of
mSCs following injury. Mice were treated as in A, but
EdU was administered by IP, 3 h prior to the culling of
the animals at the indicated times. Graphs show the
percentages of all proliferating cells (EdU+/Hoechst+)
or the percentages of proliferating mSCs (YFP+,
EdU+/YFP+) at the indicated time points (n=4-6 mice,
±s.e.m.). (C) Pie charts show the cell composition and
relative contribution of each cell type to the
proliferating population in the distal stump of an injured
sciatic nerve on Day 4 following injury, which is the
peak time of proliferation (n=8 mice). The NG2+/
PDGFRβ+/p75+/αSMA− population is classified as
either associated or non-associated with CD31+ blood
vessels (BV). See also Fig. S3.
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determine the proportion of mSCs versus nmSCs, we compared the
percentage of recombined SCs in the uncut contralateral nerve with
that of SCs migrating in the bridge region of the injured nerve in
individual P0-CreERT2:tdTomato mice (Madisen et al., 2010). More
than 80% ofmSCswere tdTomato+ in the uninjured nerve (Fig. S4B),
yet in three of four mice analysed, the proportion of recombined SCs
was lower in the bridge than in the contralateral uncut nerve (Fig. 4E,
Fig. S4D). These results suggest that both nmSC- and mSC-derived
cells migrate into the bridge following injury, but that nmSC-derived
cells tend to make a greater contribution to this process.
A second role for SCs during the regenerative response is to
contribute to the clearance of the axonal and myelin debris that
accumulates in the distal stump, as the axons degenerate and mSCs
dedifferentiate following a transection injury (Brosius Lutz et al.,
2017; Fernandez-Valle et al., 1995; Gomez-Sanchez et al., 2015).
Using P0-CreERT2:tdTomatomice, we could visualise mSC-derived
cells that had engulfed myelin debris in the distal stump of injured
nerves (Fig. S4E), consistent with previous studies suggesting that
cells derived from mSCs are able to clear the debris in injured nerves
(Brosius Lutz et al., 2017). In contrast, p75+/tdTomato− cells do not
appear to contain myelin debris, probably reflecting that nmSCs do
not have access to the myelin debris.
The regenerated nerve has structural abnormalities
It is well established that a regenerated nerve is distinct from an
uninjured nerve. In particular, there is an increase in the number of
axons owing to increased axonal sprouting during the regenerative
process (Bray and Aguayo, 1974; Fawcett and Keynes, 1990; Friede
and Bischhausen, 1980; Gutmann and Sanders, 1943). Using EM
and the cell-specific markers characterised above, we performed a
detailed analysis of the structure and cell composition of the fully
regenerated nerve at 6 months following injury. Consistent with
previous studies (Salonen et al., 1988; Zochodne, 2008), we found
an increase in the density and number of myelinated axons in
regenerated nerves and a decrease in the average size of these axons
(Fig. 5A,B, Fig. S5B,C). We also detected a striking difference in
Fig. 4. mSCs become migratory following injury to
guide regrowing axons across the injury site.
(A) Representative images of transverse (left) and
longitudinal (right) cryosections of uninjured contralateral
sciatic nerve, showing the high recombination rate in
P0-CreERT2:Confetti mice following tamoxifen
administration. Nuclei were labelled with RedDot (left), and
anti-p75 antibody was used to label nmSCs (right).
(B) Representative longitudinal cryosection of a transected
sciatic nerve (left). The dashed line boxed area is shown at
higher magnification on the right, showing that cells derived
from mSCs have migrated into the nerve bridge at Day 6
following nerve injury. An antibody against p75 was used to
label dedifferentiated SCs. P, proximal; D, distal.
(C) Representative longitudinal cryosection of the bridge of
a transected sciatic nerve (left). The dashed line boxed area
is shown at higher magnification on the right. Arrowhead
indicates a cord of two migrating SCs that have derived from
different mSCs (YFP+ and RFP+). (D) Representative
images of longitudinal sections of an uninjured and
transected sciatic nerve on Day 6 following injury shows that
dedifferentiated SCs derived from mSCs associate with
axons while migrating into the nerve bridge. An antibody
against neurofilament (NF) was used to label the axons
(white). Arrowheads indicate migrating SCs associated with
axons. (E) Graph shows the percentage of recombined SCs
[tdTomato/(mSCs+nmSCs)] in the bridge of the injured
sciatic nerve of P0-CreERT2:tdTomato mice on Day 6 after
injury and in the contralateral uninjured sciatic nerve (uncut).
Each coloured dot represents an individual animal. Lines
show mean±s.e.m. See also Fig. S4.
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the structure of Remak bundles with a large decrease in the number
of axons within individual Remak structures (Fig. 5A,B).
The regenerated nerves also showed a more than threefold
increase in cell density (Fig. 5C). This represented a proportional
increase of all cell types within the nerve (Fig. 5D,E, Fig. S5A,B),
indicating that interactions between the cell types act to maintain the
composition of the tissue, with the increased number of nmSCs
likely explaining the decreased number of axons within each Remak
structure. Importantly, we were able to identify all the cells within
the regenerated nerve (Fig. 5E), suggesting that all cell types retain
their identity during the regeneration process.
A striking observation was that, in regenerated nerve, the level of
extracellular matrix (ECM) was dramatically different compared
with that in an uninjured nerve. ECM levels increase during an
injury/regenerative process (Eming et al., 2017), but we found that
the additional ECM was not cleared from the regenerated nerve.
There were much higher levels of laminin deposition within the
basal lamina around the SCs and blood vessels in regenerated nerve
(Fig. 6A,B). Moreover, the levels of fibronectin and collagen III
were considerably higher throughout the regenerated nerve (Fig. 6A,
B). These findings are consistent with the perceived fibrotic nature
of repaired tissue and suggest that, whereas many cellular changes
and the inflammatory response associated with a regenerative
process successfully resolve, the increased ECM deposition
associated with tissue regeneration remains within the tissue.
mSCs maintain their identity during regeneration but show
increased plasticity during tumourigenesis
It has previously been shown that adult SCs retain a level of
multipotency (Adameyko et al., 2009; Kaukua et al., 2014; Masaki
et al., 2013; Widera et al., 2011). However, these studies were mostly
in relatively non-physiological situations, and it has been shown for
other cell types that the environmental context can influence cell
plasticity (Anderson, 2001). In particular, a recent study showed that
the reported multipotency of pericytes in vitro was not recapitulated
when lineage analysis was performed in the animal (Guimarães-
Fig. 5. Regenerated nerve is distinct from
uninjured nerve. (A) Representative EM
images of uncut contralateral or regenerated
nerve taken 6 months following injury. Note that
the regenerated nerve has smaller axons and
more myelinated axons per field compared with
the uncut nerve. The lower panels show a higher
magnification of the EM images, in which
nmSCs are highlighted in green and small
calibre axons in orange to show the decreased
numbers of axons per Remak bundle in the
regenerated nerve. (B) Quantifications of A,
showing the density of myelinated axons, the
number of axons per Remak bundle (n=3 mice,
mean±s.e.m.) and the axon diameters (n=8
mice) in uncut and regenerated nerve.
(C) Representative confocal images of
transverse sections of uninjured and
regenerated sciatic nerve, 6 months after injury,
showing Hoechst+ cells (blue). Graph shows the
quantification of the number of nuclei per field
(n=8 mice, mean±s.e.m.). (D) Cryosections of
regenerated and uninjured sciatic nerve were
immunolabelled for cell type-specific markers as
indicated, 6 months following injury, and the
number of the different cell types was quantified
per field (n=4-8 mice, mean±s.e.m., two-way
ANOVA was used). (E) Pie chart shows the cell
composition of regenerated sciatic nerve
6 months following injury (n=4-8 mice). The
NG2+/PDGFRβ+/p75+/αSMA− population is
classified as either associated or non-
associated with CD31+ blood vessels (BV). See
also Fig. S5. *P<0.05, **P<0.01, ***P<0.001.
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Camboa et al., 2017). To address the plasticity of mSCs, we used
lineage analysis to track the fate of mSCs following injury. We then
compared the behaviour of normal mSCs following injury with those
in a mouse model of NF1 tumourigenesis, in which tumours derive
from mSCs (Ribeiro et al., 2013). For the injury studies, we treated
either P0-CreERT2:YFP or P0-CreERT2:Confetti mice with
tamoxifen 14 days prior to injury, and harvested the injured and
contralateral uninjured nerves 6 months later. Analysis of these
nerves showed that the vast majority of the labelled mSCs
redifferentiated to mSCs, as shown by their morphology and
association with large calibre axons and P0 staining (Fig. 7A, Fig.
S6). Importantly, by pulse labelling mice with a single dose of EdU,
3 days after the injury, we were able to show that mSCs that
dedifferentiated and proliferated shortly after injury remyelinated
normally, as we could detect YFP+/EdU+ mSCs within the
regenerated nerve (Fig. S6). To determine whether cells derived
frommSCs contributed proportionally to the new mSC population in
regenerated nerve, we compared the rate of recombination in the
contralateral nerves with that in the distal regenerated nerve in mice
with lower recombination rates. We found that the proportions
remained the same (Fig. 7B), providing strong evidence that an
additional stem cell or progenitor population was not contributing to
the production of mSCs in the regenerated nerve. In contrast, the
percentage of recombined cells was lower in some animals in the
region of the cut site (Fig. 7B). This is consistent with our findings
that, in some animals, proportionally fewer mSCs migrated into the
bridge region compared with those derived from nmSCs (Fig. 4E).
To determine whether cells derived from mSCs retained any
plasticity, we initially addressed whether these cells could become
nmSCs.Weanalysed the new tissue of thebridge region,where the loss
of the Bands of Büngner may permit greater contact with smaller
axons, and found several examples of labelled SCs that had
redifferentiated to become nmSCs, as shown by their association
with small calibre axons in the characteristic structure of a Remak
bundle (Fig. 7C). We also found these cells within the distal stump
region. To confirm these findings, we performed correlative light and
EM (CLEM) and foundmultiple examples of labelled Remak bundles
in the regenerated nerves (Fig. 7D, Fig. S7). These findings show
definitively thatmSCs retain theplasticity to becomenmSCs following
an injury. Moreover, the finding that there was a decrease in the
proportion of labelled cells in the bridge region of the cut (Fig. 7B)
suggests that SCs derived from nmSCs make a contribution to the
regenerated mSC population in this new tissue. Together, these
findings indicate that dedifferentiated SCs from both the nmSC and
mSC population are able to switch between their respective roles.
In contrast to this limited plasticity, we did not find a single
example of a mSC becoming another cell type within the
regenerated nerve. These findings suggest, as has been shown for
other cell types, that the reported plasticity of cells is the result of the
non-physiological environment in which the experiments were
performed, and that the microenvironment is important for
maintaining cell identity (Guimarães-Camboa et al., 2017;
Snippert and Clevers, 2011). Consistent with this view, we found
a different scenario in the tumour mouse model (P0-CreERT2:YFP:
Nf1fl/fl), in which, following an injury, tumours derived from mSCs
only develop at the injury site (Ribeiro et al., 2013). Analysis of
these nerves showed that, although cells derived from Nf1−/−mSCs
mostly redifferentiated into mSCs or became tumour cells, a
Fig. 6. The levels of ECM proteins
remain high in regenerated nerve.
(A) Representative confocal images of
transverse sections of uninjured sciatic
nerve, and the distal stump of regenerated
sciatic nerve, 6 months following injury,
immunostained for the indicated ECM
proteins. (B) Graphs show quantifications
of A (n=6 mice, mean±s.e.m.). *P<0.05,
**P<0.01, ***P<0.001.
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proportion appeared to become other cell types (Fig. 7E). These
included a large number of cells that expressed Glut1 and resembled
perineurial-like cells within the tumour mass (Fig. 7E). Moreover,
we found several examples of YFP+ cells that had integrated into the
perineurium (Fig. 7E). These cells were never seen in control
animals or in the distal stump of P0-CreERT2:YFP:Nf1fl/fl animals.
These findings demonstrate that SCs retain their identity within the
context of a regenerating nerve and exhibit limited plasticity,
whereas a tumourigenic genetic change and the microenvironment
can synergise to increase the plasticity of these cells.
DISCUSSION
It is becoming increasingly clear that different tissues have distinct
mechanisms to maintain themselves in the adult and to repair following
an injury (Ge and Fuchs, 2018; Varga and Greten, 2017; Wells and
Watt, 2018). In proliferative tissues, the classical model of a defined
stem cell population dividing infrequently to produce a transiently
amplifying population, which then differentiates to produce the various
cells of a tissue, has been supplanted by more diverse models.
These include stem cells that divide frequently, reserve stem cell
compartments, the ability of committed cells to dedifferentiate to form
stem cells and separate stem cell compartments that are activated upon
injury. Moreover, the mechanism to produce new cells often varies
dramatically between the homeostatic, injured and repairing states.
Here, we have systematically characterised the cells that make up
the endoneurium of peripheral nerves, although we cannot rule out a
failure to detect rare cells that are not labelled by any of our
methodologies. We find that it is a highly quiescent tissue, with most
cell types proliferating rarely, while the main cell type of the nerve,
the mSC, does not divide at all in the adult. The stability of this tissue
is presumably possible because peripheral nerves, once formed and
matured, tend to retain their structure and their connections.
Moreover, peripheral nerves are protected by the BNB, which
perhaps contributes to the low turnover rate of cells within this tissue.
However, once injured, all cell types within a peripheral nerve are
able to re-enter the cell cycle and do so at very high efficiency,
Fig. 7. mSCs retain a SC fate following nerve injury but
can switch to become a nmSC. (A) Representative confocal
images of the uncut and regenerated distal stump of P0-
CreERT2:Confetti mice, 6 months following injury. The
majority of the labelled mSCs redifferentiated back to mSCs,
as seen by their morphology and association with large
calibre axons, labelled for neurofilament (NF, white).
Arrowheads indicate examples. Nuclei are labelled in the
upper row with TO-PRO (dark blue). (B) Graphs show the
percentage of recombinedmSCs in the distal stump and at the
injury site, compared with those in the uninjured contralateral
nerve, in P0-CreERT2:Confettimice 6 months following injury.
Each coloured dot indicates an individual animal. Lines show
mean±s.e.m. (C) Representative confocal images of
transverse sections of regenerated sciatic nerves of P0-
CreERT2:Confetti mice, showing labelled mSCs that have
redifferentiated into nmSCs. Arrowheads indicate labelled
Remak bundles associated with small calibre axons (labelled
for NF, white). (D) CLEM images of a 200 μm transverse
section of sciatic nerve from a P0-CreERT2:Confettimouse at
Day 90 after nerve transection, showing an RFP-labelled
mSC (indicated by arrow) that has redifferentiated to become
a nmSC following injury. (E) Representative confocal images
showing (i) a regenerated nerve of P0-CreERT2:YFP mice, in
which mSCs retain their lineage and (ii,iii) tumours from P0-
CreERT2:YFP:Nf1fl/fl mice, which develop neurofibromas
derived from Nf1−/− mSCs specifically at the injury site.
Arrowheads indicate Nf1−/−/YFP+ mSC-derived cells, which
have taken a different cell fate within the tumour. (ii) A YFP-
positive cell, which has integrated within the perineurium. (iii)
YFP+, perineurial-like cells, which have a distinct morphology
and are labelled with Glut1, a marker of perineurial cells. See
also Figs S6 and S7.
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apparently obviating the requirement for a stem cell population to
produce new cells for the regenerative process. This switch from a
highly quiescent tissue to a highly proliferative tissue – with all cell
types contributing to the regenerative response – represents a further
model of how tissues maintain and repair themselves.
In this study, we have also characterised a new cell type. These
cells are NG2+/PDGFRβ+, the classical markers for pericytes.
However, although these cells are found loosely associated with
blood vessels, they are not found within the basal lamina and are
negative for αSMA (unlike all the pericytes detected in peripheral
nerve). They are also positive for p75+, a marker for dedifferentiated
SCs and nmSCs, but negative for S100, and are not marked in any of
our SC-specific lineage-tracing mice or in the PLP-eGFP mice.
They also have a unique morphology, with long protrusions
spreading throughout the endoneurium, which make apparent
contact with the other cell types within the nerve. Because of their
extensive endoplasmic reticulum, they have previously been
referred to as fibroblasts; however, because of their unique set of
markers and distinct morphology, we propose to call them
tactocytes (touching cells). They make up a substantial proportion
(12.5%) of the cells within a peripheral nerve and future studies are
needed to uncover their roles in nerve function.
We have characterised the behaviour of the mSC in most detail,
which has been possible because of a highly specific driver for this
cell type in adulthood that permits credible lineage analysis. These
studies show that the mSC is a truly remarkable cell. We were unable
to detect a single proliferating mSC throughout the nerves of multiple
animals, which indicates that, once formed, these highly specialised
cells do not turn over. However, these cells are not postmitotic. Using
lineage analysis, wewere able to show that, following an injury, close
to 100% of mSCs proliferated within a few days of the injury.
Moreover, they showed a dramatic change in their behaviour to
become the migratory cells that transport regrowing axons across the
injury site. The ability of all mSCs to proliferate following an injury
would seemingly indicate the lack of need for a further stem cell
population to produce new SCs during the regeneration of peripheral
nerves. This view is further substantiated by lineage analysis of
animals with lower levels of recombination, in which we found a
similar proportion of recombined mSCs in an individual animal’s
uncut and contralateral regenerated sciatic nerve, showing that the
original population is not diluted by an influx of stem cells from
another source. It could thus be argued that there is not a stem cell/
progenitor population to produce new mSCs in the adult, or that all
mSCs have the capacity to act as stem/progenitor cells. The latter
argument is augmented by studies showing that dedifferentiated SCs
have unlimited proliferative capacity (Mathon et al., 2001) and retain
the ability to redifferentiate back to a more differentiated cell state.
It is particularly striking that very different mechanisms are used to
maintain the myelinating cells of the PNS and CNS. New OLs are
produced throughout life. Although much of this is thought to be to
myelinate new axons, and is associated with learning and memory,
there also appears to be a higher turnover of mature cells, as axons in
the optic nerve are fullymyelinated yet appear to turn over throughout
adulthood (Young et al., 2013). Why mSCs are more stable than OLs
in the optic nerve is not clear, as the environments appear similar in
that they are both stable structures and are protected by the BNB and
blood-brain barrier, respectively. The mechanisms to produce new
myelinating cells are also different. There only appears to be a
requirement to produce new mSCs following injury, as normally
these cells do not turn over in the adult. However, following injury,
new cells are produced by the dedifferentiation and proliferation of
the mSCs themselves. In contrast, the CNS is populated throughout
by precursor cells (OPCs), which proliferate throughout adulthood to
maintain themselves and differentiate throughout life to produce new
OLs (Birey et al., 2017). Why such differences exist can only be
speculated upon, but they are likely to reflect a trade-off between the
increased plasticity required by the CNS versus the stability required
by the PNS. The presence of a continually proliferating progenitor
population whilst allowing a rapid source for new myelination also
provides a pool susceptible to tumour development. Consistent with
this, malignant tumours are more frequent in the CNS than in the
PNS, which perhaps reflects the presence of a more susceptible
proliferating progenitor population.
The lineage analysis used in this study indicates that, during the
regenerative process, SCs retain their identity. Studies have suggested
that SCs retain multipotency, but, similar to findings from in vivo
studies in other tissues, it appears that the normal tissue environment
restricts plasticity (Anderson, 2001; Guimarães-Camboa et al., 2017).
We found that dedifferentiated mSCs, while retaining a SC identity,
were able to become nmSCs, showing that these cells retained the
ability to respond to the axonal environment and choose between a
myelinating or non-myelinating fate. However, we found that this
lineage restriction breaks down in the context of tumourigenesis. This
required both a tumourigenic mutation (loss of Nf1) and a conducive
microenvironment. However, these findings show that increased
plasticity can be induced in the SC lineage, which potentially has
implications for the pathology of these tumours.
Peripheral nerves regenerate even following a full transection and
functionality can be restored, in contrast to the poor regenerative
capability of the CNS. However, our studies, and others, show that a
regenerated nerve differs markedly from an uninjured nerve (Napoli
et al., 2012; Salonen et al., 1988; Zochodne, 2008). This includes a
large increase in the cellularity of regenerated nerve. Notably, the
relative proportion of all cell types remained the same, indicating
that an unknown homeostatic mechanism exists to ensure the
structure of the nerve. However, the major difference appears to be
increased ECM levels in regenerated nerve. ECMdeposition is a key
aspect of an injury response (Eming et al., 2017), and it is likely that
the failure to clear the injury-induced ECM contributes to the
inability of repaired tissue to return to the uninjured state. Targeting
the clearance of accumulated ECM could thus provide a strategy for
improving tissue repair.
In summary, we report that peripheral nerve provides a further
example of the diverse mechanisms by which tissues maintain
themselves and repair following injury. In the adult, peripheral
nerve is highly quiescent yet retains function throughout adulthood.
However, despite this stability, it has remarkable regenerative
properties without the need for a specialised stem cell compartment –
instead all the cell types of the nerve are able to proliferate to
contribute to the regeneration of this tissue.
MATERIALS AND METHODS
Transgenic mice
All animal work was performed in accordance with UK Home Office
legislation. Mice were housed in a temperature- and humidity-controlled
vivarium on a 12-h light-dark cycle with free access to food and water.
Female and male (4-week- to 1-year-old) mice of the following genotypes
and strains were used: for lineage tracing of mSCs, P0-CreERT2 C57Bl/6
mice (Leone et al., 2003; Ribeiro et al., 2013) were crossed with R26R-YFP
(Srinivas et al., 2001), R26R-tdTomato (Madisen et al., 2010) or R26R-
Confetti reporter mice (Livet et al., 2007; Snippert et al., 2010) to generate
P0-CreERT2:YFP, P0-CreERT2:tdTomato and P0-CreERT2:Confetti mice.
To visualise all SCs, P0-Cre mice (Feltri et al., 1999) were crossed with
R26R-tdTomato mice to generate P0-Cre:tdTomato and Plp-eGFP
transgenic mice (Mallon et al., 2002) were used. NG2-dsRed mice were
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used to confirm the identity of NG2+ cells (Zhu et al., 2008). To distinguish
between NG2+/PDGFRβ+/p75+/αSMA− and dedifferentiated SCs within
the nerve bridge, Plp-eGFP mice were crossed with NG2-dsRed mice to
generate PLP-eGFP:NG2-dsRed mice. For genotyping primer sequences
used in this study, see Table S3.
For studying SC plasticity in a nerve tumour environment, P0-CreERT2:
YFP:Nf1fl/fl mice were used (Ribeiro et al., 2013). In all studies, both male
and female mice were used. Animals were genotyped and identified using
earhole punches upon weaning. For further details of the transgenic mice
used in this study, see Table S2. For lineage-tracing experiments, Cre-
mediated recombination was induced in 4- to 5-week-old mice by
intraperitoneal injection (IP) or oral administration of 2 mg tamoxifen
(Sigma-Aldrich, H7904) daily for 5 consecutive days. Tamoxifen was
dissolved in sunflower oil (20 mg/ml) and filtered through a 0.2 μm filter.
Sciatic nerve injury
Fourteen days after tamoxifen administration, mice were anaesthetised with
isofluorane under aseptic conditions and the right sciatic nerve was exposed
at the sciatic notch. The nerve was fully transected or half transected, as
indicated, and thewound closed with clips. Nerves were then collected at the
indicated days for analysis by immunostaining or EM.
EdU administration
To cumulatively label newly generated cells, adult c57bl/6 or PLP-eGFP
mice received 0.2 mg/ml EdU (Thermo Fisher Scientific, A10044) in their
drinking water for up to 70 days as indicated (Young et al., 2013). The water
was changed every 48 h. For pulse-labelling experiments, a single
EdU injection (2 mg of EdU in PBS) was given by IP 3 h prior to
tissue collection. Cell proliferation was determined by measuring EdU
incorporation detected using the Click-iT™ EdU kit (Thermo Fisher
Scientific, C10339) according to the manufacturer’s instructions.
IF staining
Sciatic nerves were dissected and fixed for 4 h in 4% paraformaldehyde
(TAAB) at room temperature and embedded for cryosectioning. For
immunostaining, pre- or postfixed longitudinal sections of the sciatic nerves
were immunostained as detailed in the Supplementary Materials and
Methods and analysed using confocal microscopy.
Primary antibodies
The following primary antibodies were used for IF at the indicated dilutions:
anti-P0 (1/500, Abcam, ab39375), anti-p75 (1/500, Millipore, ab1554),
anti-S100 (1/1000, Dako, Z0311), anti-Iba1 (1/500, Wako, 019-19741), anti-
CD31 (1/100, BD Biosciences, 553370), anti-neurofilament 200 kD (1/1000,
Abcam, ab4680), anti-laminin (1/500, Abcam, 11575), anti-collagen III
(1/1000, Abcam, ab7778), anti-fibronectin (1/500, Sigma-Aldrich, clone
FN-3E2), anti-NG2 (1/500, Millipore, ab5320), anti-PDGFRβ (1/500,
Abcam, ab32570), anti-αSMA (1/1000, Sigma-Aldrich, C6198), anti-GFP
(1/1000, Abcam, ab13970), anti-Glut1 (1/500, Abcam, ab652), anti-F4/80
(1/100, Bio-Rad, MCA497G) and anti-NG2 (1/100, Thermo Fisher
Scientific, MA5-24247). For further details of primary antibodies used in
this study, see Table S1.
Confocal microscopy
Confocal images were acquired using an inverted SPE or SP8 confocal
microscope (Leica). A multiphoton microscope (Zeiss) was used to image
confetti samples. Within each experiment, the same acquisition settings
were used, the same volume imaged and the same number of z-stacks
acquired. Fiji software (https://imagej.net/Fiji/Downloads) was used to
make a projection of the z-stacks. For 3D projections, Imaris software was
used (http://www.bitplane.com/imaris).
Transmission EM
Sciatic nerves were dissected and fixed overnight at 4°C in 2%
glutaraldehyde in 0.2 M phosphate buffer. Nerves were then postfixed in
2% osmium tetroxide for 1.5 h at 4°C, and incubated in 2% uranyl acetate
for 45 min at 4°C. Nerves were dehydrated in an ethanol series before being
incubated with propylene oxide and embedded in epoxy resin. Ultrathin
sections (70 nm) were cut with a diamond knife (Diatome), collected onto
formvar-coated slot grids and visualised using a transmission electron
microscope (T12 Tecnai Spirit, FEI) using a Morada camera and iTEM
software (Olympus SIS). Semithin sections were cut using a diamond Histo
knife (Diatome) at 0.2 μm, dried and stained with 1% Toluidine Blue in 2%
Borax at 75°C for 2 min. Dried sections were mounted with DPX (Sigma-
Aldrich) and representative images of the entire nerves were acquired using
a wide-field microscope (Zeiss Axio Scope.A1).
CLEM
Regenerated sciatic nerves from P0-CreERT2:Confetti mice were harvested
3 months following injury and fixed in antigenfix (Diapath) overnight. The
following day, nerves were embedded in 2.8% low melting point agarose in
PBS. Sections (200 µm) of the embedded nervewere cut in cold PBS using a
vibrating microtome. For CLEM analysis, sections were first analysed using
a SP8 confocal microscope (Leica) and then processed for EM. For further
details of the CLEM protocol used in this study, see the Supplementary
Materials and Methods.
Quantification and statistical analysis
For details of the image quantification analysis used in this study, see the
Supplementary Materials and Methods.
Statistical analysis
Statistical and graphical data analyses were performed using Prism 7
(GraphPad). For all measurements, three or more biological replicates were
used. Information regarding the number of biological replicates (‘n’) used in
each experiment is reported in the relevant figure legends. The data are
presented as mean± s.e.m. Unpaired two-tailed Student’s t-test was used for
statistical analysis, except where ANOVA is indicated. *P<0.05, **P<0.01,
***P<0.001.
Acknowledgements
We thank UCL Biological Services, David Attwell and Michael Hausser for mice,
and members of the Lloyd laboratory for helpful discussions.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: S.S., I.N., A.C.L.; Methodology: S.S., I.N., A.C.L.; Validation:
A.C.L.; Formal analysis: S.S., I.N.; Investigation: S.S., I.N., I.J.W., A.-L.C., A.M.C.,
N.G.C., L.M., S.R., J.N., R.W., K.M.Y.; Resources: K.M.Y., W.D.R.; Writing - original
draft: S.S., I.N., A.C.L.; Visualization: S.S., I.N., A.-L.C.; Supervision: I.N., A.C.L.;
Project administration: A.C.L.; Funding acquisition: A.C.L.
Funding
This work was supported by a Cancer Research UK Programme Grant [C378] and a
Cancer Research UK PhD Studentship [C36048 to S.S.], the Medical Research
Council (MRC) [MR/N009169/1; MC_U12266B to theMRC Laboratory for Molecular
Cell Biology University Unit at UCL], a Multiple Sclerosis Research Australia and
Macquarie University Paired Fellowship [17-0223], and Alzheimer’s Society/BUPA
Foundation [22095095 to K.M.Y.]. Deposited in PMC for immediate release.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.170316.supplemental
References
Adameyko, I., Lallemend, F., Aquino, J. B., Pereira, J. A., Topilko, P., Müller, T.,
Fritz, N., Beljajeva, A., Mochii, M., Liste, I. et al. (2009). Schwann cell precursors
from nerve innervation are a cellular origin of melanocytes in skin.Cell 139, 366-379.
Amoh, Y., Li, L., Campillo, R., Kawahara, K., Katsuoka, K., Penman, S. and
Hoffman, R. M. (2005). Implanted hair follicle stem cells form Schwann cells that
support repair of severed peripheral nerves. Proc. Natl. Acad. Sci. USA 102,
17734-17738.
Anderson, D. J. (2001). Stem cells and pattern formation in the nervous system: the
possible versus the actual. Neuron 30, 19-35.
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